Press What’s news at AbelsonTaylor Group
Select category
Agency 100 Studio Session: AbelsonTaylor | The future of generative AI in pharma marketing
AT’s VP – Director of Engagement Strategy Sharlene Jenner discusses some of the opportunities and challenges generative AI will bring in the future of pharma marketing. Through this podcast, Sharlene discusses how marketers must bring their teams together to maximize the new technology, while also trying to gain a better understanding of privacy laws, and intellectual property protection.
Read more at MM+M Online.
Media Contact:
Recent Posts
Six steps to navigating the future of pharmaceutical advertising
Terence Prudhomme, Senior Media Director for AT Activate, discusses six steps to optimizing the evolving media landscape for pharma advertisers to communicate...
Read Press Read more Six steps to navigating the future of pharmaceutical advertisingHow will medical marketing’s DE&I efforts fare in 2025?
Antonio Rivera, director of engagement at AbelsonTaylor Group, discusses how as AI becomes more embedded in healthcare and marketing, it...
In the News Read more How will medical marketing’s DE&I efforts fare in 2025?Social Media Marketing Trends 2025 Report
Thenetworkone just released its annual industry resource on social media trends, including expert insights from AT Group’s Associate Director of Engagement...
In the News Read more Social Media Marketing Trends 2025 ReportConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.